Koyfin Home > Directory > Health Care > Ampio Pharmaceuticals > EBITDA

Ampio Pharmaceuticals EBITDA Chart (AMPE)

Ampio Pharmaceuticals annual/quarterly EBITDA from 2010 to 2018. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Ampio Pharmaceuticals EBITDA for the quarter ending September 09, 2018 was $-2m a -182.51% increase of 3m year over year
  • Ampio Pharmaceuticals EBITDA for the last 12 months ending September 09, 2018 was $-12m a -18.81% increase of 2m year over year
  • Ampio Pharmaceuticals Annual EBITDA for 2017 was $-14m a -10.57% increase of 2m from 2016
  • Ampio Pharmaceuticals Annual EBITDA for 2016 was $-16m a -47.11% increase of 7m from 2015
  • Ampio Pharmaceuticals Annual EBITDA for 2015 was $-23m a -33.26% increase of 8m from 2014
Other Income Statement Metrics:
  • Ampio Pharmaceuticals Net Income for the quarter ending September 09, 2018 was $6m a 843.40% increase of 49m year over year
  • Ampio Pharmaceuticals Total Revenue for the quarter ending December 12, 2015 was $0m a 95.43% increase of 0m year over year
View Chart On Koyfin

Quarterly AMPE EBITDA Data

09/2018$-2m
06/2018$-3m
03/2018$-3m
12/2017$-5m
09/2017$-3m
06/2017$-4m
03/2017$-3m
12/2016$-3m
09/2016$-3m
06/2016$-4m

Annual AMPE EBITDA Data

2017$-14m
2016$-16m
2015$-23m
2014$-31m
2013$-24m
2012$-12m
2011$-11m
2010$-7m